Liver Disease
Conference Coverage
Short-Course Vasoconstrictors After EVL: Time for a New Standard of Care?
“This approach would allow earlier discharge from the hospital and reduce the risk of adverse events,” said Dr. Sushrut Ingawale.
From the AGA Journals
MASH: Experts Offer Noninvasive Cutoffs for Prescribing Resmetirom
This guidance document allows clinicians to use a variety of NITs to start and monitor resmetirom therapy.
Latest News
Can We Repurpose Obesity Drugs to Reverse Liver Disease?
A new retrospective observational study offers evidence that GLP-1 RAs may have a direct impact on MASLD,...
Member Spotlight
Giving the Smallest GI Transplant Patients a New Lease On Life
As medical director of intestinal transplant at Stanford Children’s Health, Dr. Yoyo Zhang sees children with critical illnesses like intestinal...
From the AGA Journals
MASLD Healthcare Costs Climbing Fast in Canada
Over 90% of the healthcare costs for MASLD patients were attributed not to liver disease itself but to the management of associated comorbidities...
Feature
AI-Assisted Pathology Poised to Transform Liver Disease Care
The standardization and reproducibility offered by AI-driven technology could facilitate more consistent diagnoses across different healthcare...
From the AGA Journals
Baveno VI Criteria Appear Cost-Effective for Detecting Varices in Cirrhosis
Previous research indicates that the expanded criteria could avoid double the number of endoscopies.
Latest News
Alcohol-Associated Liver Disease’s Changing Demographics
Recent data have identified three demographic groups experiencing higher rates of ALD relative to previous periods and who may therefore require...
News from the FDA/CDC
FDA Grants Livdelzi Accelerated Approval for Primary Biliary Cholangitis
The FDA approved Livdelzi based largely on results of the phase 3 RESPONSE study.
From the Journals
Combination Therapy Looks Promising for Hepatitis D
The combination resulted in higher rates of HDV RNA suppression levels at 24 weeks after end of treatment, especially at a higher, 10-mg dose of...